ARID2 Deficiency Enhances Tumor Progression via ERBB3 Signaling in TFE3-Rearranged Renal Cell CarcinomaTomomi Kamba(Kyoto University)Current Issues in Molecular BiologyDecember 2, 202410.3390/cimb46120817Cited by 3SaveCiteExport RISWatch citationsRelated PapersRole of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma|PLoS ONE|2015|44